According to Illumina's latest financial reports the company has $1.05 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $1.05 B | -48.26% |
2022-12-31 | $2.03 B | 52.13% |
2021-12-31 | $1.33 B | -61.43% |
2020-12-31 | $3.47 B | 1.7% |
2019-12-31 | $3.41 B | -2.79% |
2018-12-31 | $3.51 B | 63.73% |
2017-12-31 | $2.14 B | 37.59% |
2016-12-31 | $1.55 B | 12.46% |
2015-12-31 | $1.38 B | 3.58% |
2014-12-31 | $1.33 B | 14.82% |
2013-12-31 | $1.16 B | -13.67% |
2012-12-31 | $1.35 B | 13.5% |
2011-12-31 | $1.18 B | 33.02% |
2010-12-31 | $0.89 B | 28.95% |
2009-12-31 | $0.69 B | 8.35% |
2008-12-31 | $0.64 B | 65.79% |
2007-12-31 | $0.38 B | 195.16% |
2006-12-31 | $0.13 B | 157.38% |
2005-12-31 | $50.82 M | -7.24% |
2004-12-31 | $54.78 M | 67.13% |
2003-12-31 | $32.78 M | -39.03% |
2002-12-31 | $53.76 M | -40.59% |
2001-12-31 | $90.49 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $8.07 B | 666.32% | ๐บ๐ธ USA |
Agilent Technologies A | $1.74 B | 65.84% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $0.68 B | -34.91% | ๐บ๐ธ USA |
Danaher DHR | $5.86 B | 456.36% | ๐บ๐ธ USA |
PerkinElmer
PKI | $2.46 B | 133.51% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | N/A | N/A | ๐บ๐ธ USA |
Pacific Biosciences
PACB | $0.63 B | -40.09% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |